Insider Transactions in Q1 2025 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
421
-4.46%
|
$25,260
$60.58 P/Share
|
|
Mar 24
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
421
+4.27%
|
$5,473
$13.56 P/Share
|
|
Mar 24
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
1,697
-1.94%
|
$101,820
$60.58 P/Share
|
|
Mar 24
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
1,697
+1.91%
|
$8,485
$5.05 P/Share
|
|
Mar 24
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,974
-0.07%
|
$118,440
$60.83 P/Share
|
|
Mar 20
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
466
+2.09%
|
-
|
|
Mar 12
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
2,000
+8.57%
|
-
|
|
Mar 12
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
4,625
-19.69%
|
-
|
|
Mar 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$116,600
$53.6 P/Share
|
|
Mar 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Mar 04
2025
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-78.47%
|
$1,180,000
$59.07 P/Share
|
|
Mar 04
2025
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+43.97%
|
$380,000
$19.26 P/Share
|
|
Mar 03
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
18,303
-17.61%
|
$1,098,180
$60.69 P/Share
|
|
Mar 03
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
18,303
+14.97%
|
$91,515
$5.05 P/Share
|
|
Mar 03
2025
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
532
+0.31%
|
$15,428
$29.54 P/Share
|
|
Mar 03
2025
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-0.27%
|
$13,680
$60.58 P/Share
|
|
Mar 03
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
4,579
-33.7%
|
$274,740
$60.69 P/Share
|
|
Mar 03
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
4,579
+25.21%
|
$59,527
$13.56 P/Share
|
|
Mar 03
2025
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
432
+2.37%
|
$12,528
$29.54 P/Share
|
|
Mar 03
2025
|
Joseph Douglas Lyon |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-2.08%
|
$10,920
$60.58 P/Share
|
|
Mar 03
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,924
-0.1%
|
$175,440
$60.91 P/Share
|
|
Mar 03
2025
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
464
+1.76%
|
$13,456
$29.54 P/Share
|
|
Mar 03
2025
|
Atabak Mokari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-1.78%
|
$13,680
$60.58 P/Share
|
|
Mar 03
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
584
+1.24%
|
$16,936
$29.54 P/Share
|
|
Mar 03
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-1.08%
|
$15,000
$60.58 P/Share
|
|
Feb 11
2025
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,176
-31.71%
|
$5,791,968
$68.11 P/Share
|
|
Feb 11
2025
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+35.84%
|
$450,000
$3.29 P/Share
|
|
Feb 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$149,600
$68.08 P/Share
|
|
Feb 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Feb 03
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-36.34%
|
$330,000
$66.92 P/Share
|
|
Feb 03
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.58%
|
$60,000
$12.46 P/Share
|
|
Feb 03
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-18.99%
|
$1,320,000
$66.92 P/Share
|
|
Feb 03
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.02%
|
$80,000
$4.47 P/Share
|
|
Jan 27
2025
|
James N Wilson |
SELL
Bona fide gift
|
Indirect |
7,800
-0.54%
|
-
|
|
Jan 22
2025
|
James N Wilson |
BUY
Other acquisition or disposition
|
Indirect |
146,742
+9.17%
|
-
|
|
Jan 22
2025
|
James N Wilson |
SELL
Bona fide gift
|
Direct |
146,742
-100.0%
|
-
|
|
Jan 22
2025
|
James N Wilson |
SELL
Payment of exercise price or tax liability
|
Direct |
103,258
-41.3%
|
$6,092,222
$59.03 P/Share
|
|
Jan 22
2025
|
James N Wilson |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+50.0%
|
$750,000
$3.29 P/Share
|
|
Jan 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$110,000
$50.54 P/Share
|
|
Jan 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Jan 03
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+11.59%
|
$9,111
$3.29 P/Share
|
|
Jan 02
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-18.99%
|
$1,000,000
$50.39 P/Share
|
|
Jan 02
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.96%
|
$60,000
$3.88 P/Share
|
|
Jan 02
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-36.34%
|
$250,000
$50.39 P/Share
|
|
Jan 02
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+26.65%
|
$55,000
$11.35 P/Share
|
|
Jan 02
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,000
-35.35%
|
$550,000
$50.5 P/Share
|
|
Jan 02
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.12%
|
$33,000
$3.29 P/Share
|
|
Jan 01
2025
|
G Leonard Baker Jr Director |
SELL
Bona fide gift
|
Indirect |
0
|
-
|